GLAUKOS Corp Depreciation
GLAUKOS Corp (GKOS) reported Depreciation of $5.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-29
- GLAUKOS Corp depreciation for the quarter ending 2026-06-30 was $2.99M, a 9.83% increase year-over-year.
- GLAUKOS Corp depreciation for the quarter ending 2026-03-31 was $2.91M, a 9.73% increase year-over-year.
- GLAUKOS Corp depreciation for the quarter ending 2025-12-31 was $2.81M, a 1.59% increase year-over-year.
- GLAUKOS Corp depreciation for the quarter ending 2025-09-30 was $2.78M, a 1.24% increase year-over-year.
- GLAUKOS Corp depreciation for fiscal 2025 was $10.96M, a 0.15% increase from fiscal 2024.
- GLAUKOS Corp depreciation for fiscal 2024 was $10.95M, a 25.25% increase from fiscal 2023.
- GLAUKOS Corp depreciation for fiscal 2023 was $8.74M, a 31.18% increase from fiscal 2022.
- GLAUKOS Corp depreciation for fiscal 2022 was $6.66M, a 40.32% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $5.90M 10-Q · filed 2026-07-29 | $8.71M derived: sum of 3 quarters · filed 2026-07-29 | $11.49M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $2.91M 10-Q · filed 2026-04-30 | $5.72M derived: sum of 2 quarters · filed 2026-04-30 | $8.50M derived: sum of 3 quarters · filed 2026-04-30 | $11.22M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.59M derived: sum of 2 quarters · filed 2026-02-23 | $8.31M derived: sum of 3 quarters · filed 2026-07-29 | $10.96M 10-K · filed 2026-02-23 |
| 2025-09-30 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $5.50M derived: sum of 2 quarters · filed 2026-07-29 | $8.15M 10-Q · filed 2025-10-31 | $10.92M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $5.38M 10-Q · filed 2026-07-29 | $8.14M derived: sum of 3 quarters · filed 2026-07-29 | $10.89M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $2.65M 10-Q · filed 2026-04-30 | $5.42M derived: sum of 2 quarters · filed 2026-04-30 | $8.16M derived: sum of 3 quarters · filed 2026-04-30 | $10.91M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.51M derived: sum of 2 quarters · filed 2026-02-23 | $8.26M derived: sum of 3 quarters · filed 2026-02-23 | $10.95M 10-K · filed 2026-02-23 |
| 2024-09-30 | $2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $5.50M derived: sum of 2 quarters · filed 2025-10-31 | $8.18M 10-Q · filed 2025-10-31 | $10.47M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $5.44M 10-Q · filed 2025-08-04 | $7.72M derived: sum of 3 quarters · filed 2026-02-23 | $9.95M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $2.69M 10-Q · filed 2025-05-01 | $4.97M derived: sum of 2 quarters · filed 2026-02-23 | $7.20M derived: sum of 3 quarters · filed 2026-02-23 | $9.35M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $4.51M derived: sum of 2 quarters · filed 2026-02-23 | $6.66M derived: sum of 3 quarters · filed 2026-02-23 | $8.74M 10-K · filed 2026-02-23 |
| 2023-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $4.38M derived: sum of 2 quarters · filed 2024-11-05 | $6.46M 10-Q · filed 2024-11-05 | $8.41M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $4.23M 10-Q · filed 2024-08-02 | $6.18M derived: sum of 3 quarters · filed 2025-02-25 | $7.85M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $2.08M 10-Q · filed 2024-05-03 | $4.03M derived: sum of 2 quarters · filed 2025-02-25 | $5.70M derived: sum of 3 quarters · filed 2025-02-25 | $7.36M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $3.62M derived: sum of 2 quarters · filed 2025-02-25 | $5.28M derived: sum of 3 quarters · filed 2025-02-25 | $6.66M 10-K · filed 2025-02-25 |
| 2022-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $3.33M derived: sum of 2 quarters · filed 2023-11-01 | $4.71M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $3.04M 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $1.38M 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $4.75M 10-K · filed 2024-02-23 | |||
| 2020-12-31 | $4.47M 10-K · filed 2023-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |